Skip to content

Calidris Bio

Active
Private limited companyfounded 20197 yrs activeOlieweg 95, 2020 Antwerpen, BelgiumKBO/BCE: BE 0719.970.820
Summary

Calidris Bio has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show negative equity (-€26,175) and a net result of -€17,642. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 636 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.3% (low).

Checked score

Score 2024
Axes · tick = 2023
Profitability14▲+4
Solvency20▼-12
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.97 against 1.37 in 2023; short-term debt: 43.9% and cash: 17.5% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
-5.3%
Return on assets
-3.6%
Age of the figures
21 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
192021222324
2019 to 2024 · latest year -€26,175
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
42 d early
2024
15 d early
2023
8 d early
2022
38 d early
2021
4 d early
2020
3 d early
2019
30 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 20 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 16 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Calidris Bio was incorporated on 7 February 2019.1 Total assets rose from EUR 47,774 in 2019 to EUR 490,060 in 2024 and headcount from 0.8 full-time equivalents in 2020 to 2.3 in 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019, 2020 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
-€26,175
2023 · €44,074
Total assets
€490,060▼ 18.9%
2023 · €604,192
Net result
-€17,642▲ 57.1%
2023 · -€41,103
Working capital
-€6,073
2023 · €74,057
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result-€25,165-€61,095▼ 143%-€65,559▼ 7.3%-€89,964▼ 37.2%-€65,479▲ 27.2%
Net result-€21,542below the sector's middle half-€40,502below the sector's middle half▼ 88.0%-€37,698below the sector's middle half▲ 6.9%-€41,103below the sector's middle half▼ 9.0%-€17,642below the sector's middle half▲ 57.1%
Equity€123,445within the sector's middle half▲ 287%€168,960within the sector's middle half▲ 36.9%€98,875within the sector's middle half▼ 41.5%€44,074within the sector's middle half▼ 55.4%-€26,175below the sector's middle half
Total assets€213,143within the sector's middle half▲ 346%€302,497within the sector's middle half▲ 41.9%€747,648above the sector's middle half▲ 147%€604,192within the sector's middle half▼ 19.2%€490,060within the sector's middle half▼ 18.9%
Debt€89,699▲ 466%€133,537▲ 48.9%€648,774▲ 386%€560,118▼ 13.7%€516,235▼ 7.8%
Working capital-€59,171below the sector's middle half-€98,541below the sector's middle half▼ 66.5%€329,495above the sector's middle half€74,057within the sector's middle half▼ 77.5%-€6,073below the sector's middle half
Solvency57.9%within the sector's middle half▼ 8.9pp55.9%within the sector's middle half▼ 2.1pp13.2%below the sector's middle half▼ 42.6pp7.3%below the sector's middle half▼ 5.9pp-5.3%below the sector's middle half▼ 12.6pp
Current ratio0.18below the sector's middle half▼ 2.480.22below the sector's middle half▲ 0.033.41within the sector's middle half▲ 3.191.37within the sector's middle half▼ 2.040.97below the sector's middle half▼ 0.39
Return on assets (ROA)-10.1%below the sector's middle half▼ 60.2pp-13.4%below the sector's middle half▼ 3.3pp-5.0%below the sector's middle half▲ 8.3pp-6.8%below the sector's middle half▼ 1.8pp-3.6%below the sector's middle half▲ 3.2pp
Staff (FTE)0.8within the sector's middle half0.5▼ 37.5%0.5=1.4▲ 180%2.3▲ 64.3%
above within below the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000-€75,000-€50,000-€25,000€0Operating result 2020: -€25,165-€25,165Net result 2020: -€21,542-€21,542Operating result 2021: -€61,095-€61,095Net result 2021: -€40,502-€40,502Operating result 2022: -€65,559-€65,559Net result 2022: -€37,698-€37,698Operating result 2023: -€89,964-€89,964Net result 2023: -€41,103-€41,103Operating result 2024: -€65,479-€65,479Net result 2024: -€17,642-€17,64220202021202220232024-€100,000-€75,000-€50,000-€25,000€0Operating result 2022: -€65,559-€65,600Net result 2022: -€37,698-€37,700Operating result 2023: -€89,964-€90,000Net result 2023: -€41,103-€41,100Operating result 2024: -€65,479-€65,500Net result 2024: -€17,642-€17,600202220232024
The operating result stays negative: a loss of €65,479 in 2024 against €89,964 in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €490,060
Fixed assets €281,181 ▼ 14.1%
Current assets €208,879 ▼ 24.5%
Key figures and ratios
2024 value · change against 2023
EBITDA
-€7,157▲
2023 · -€42,809
Cash flow
€40,680▲
2023 · €6,053
Debt to equity
-19.72▼
2023 · 12.71
Interest coverage
-1.50▲
2023 · -10.14
Debt ≤ 1 year
€214,952▲
2023 · €202,703
Debt > 1 year
€248,192▲
2023 · €51,143
Staff costs
€167,841▲
2023 · €67,265
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,564 companies that looked in July 2024 the way this one looks now, 5.1% went bankrupt within 24 months and 89% are still going.

  • Micro
  • 5 to 10 years old
  • negative equity
  • a small loss
5.1% went bankrupt
5.4% stopped otherwise
89% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,564 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 48 lines
Balance sheet Code20232024
Assets
Total assets20/58€604,192€490,060▼
Fixed assets21/28€327,432€281,181▼
Intangible fixed assets21€235,301€206,018▼
Tangible fixed assets22/27€87,411€70,443▼
Plant, machinery and equipment23€14,224€16,334▲
Furniture and vehicles24€160€683▲
Leasing and similar rights25€73,028€53,426▼
Financial fixed assets28€4,720€4,720=
Current assets29/58€276,759€208,879▼
Amounts receivable within one year40/41€274,533€123,349▼
Other amounts receivable41€274,533€123,349▼
Cash at bank and in hand54/58€2,226€85,529▲
Deferred charges and accrued income490/1€0-
Equity and liabilities
Total equity and liabilities10/49€604,192€490,060▼
Equity10/15€44,074-€26,175▼
Contributions10/11€20,000€20,000=
Reserves13€1,485€1,485=
Non-distributable reserves130/1€1,485€1,485=
Reserves not available under the articles1311€1,485€1,485=
Profit (loss) carried forward14-€118,402-€136,043▼
Investment grants15€140,991€88,384▼
Amounts payable17/49€560,118€516,235▼
Amounts payable after more than one year17€51,143€248,192▲
Financial debts170/4€51,143€248,192▲
Amounts payable within one year42/48€202,703€214,952▲
Current portion of amounts payable after more than one year42€12,156€12,951▲
Financial debts43€25,000€0▼
Credit institutions430/8€25,000€0▼
Trade debts44€110,065€159,662▲
Suppliers440/4€110,065€159,662▲
Taxes, remuneration and social security45€9,749€11,224▲
Remuneration and social security454/9€9,749€11,224▲
Other amounts payable47/48€45,732€31,114▼
Accrued charges and deferred income492/3€306,272€53,091▼
Income statement Code20232024
Remuneration, social security and pensions62€67,265€167,841▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€47,155€58,322▲
Other operating charges640/8€557€952▲
Gross operating margin9900€25,013€161,636▲
Operating profit (loss)9901-€89,964-€65,479▲
Financial income75/76B€53,082€52,613▼
Recurring financial income75€53,082€52,613▼
Financial charges65/66B€4,221€4,776▲
Recurring financial charges65€4,221€4,776▲
Profit (loss) for the period before taxes9903-€41,103-€17,642▲
Profit (loss) for the period9904-€41,103-€17,642▲
Profit (loss) for the period to be appropriated9905-€41,103-€17,642▲
Appropriation of the result
Profit (loss) to be appropriated9906-€118,402-€136,043▼
Profit (loss) brought forward from the previous period14P-€77,299-€118,402▼

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Remuneration, social security and pensions62-€20,172€31,695€67,265€167,841▲ 150%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,242€28,203€38,410€47,155€58,322▲ 23.7%
Other operating charges640/8-€594€1,097€557€952▲ 70.8%
Gross operating margin9900€9,901-€12,126€5,644€25,013€161,636▲ 546%
Operating profit (loss)9901-€25,165-€61,095-€65,559-€89,964-€65,479▲ 27.2%
Financial income75/76B-€18,983€32,387€53,082€52,613▼ 0.9%
Recurring financial income75€3,943€18,983€32,387€53,082€52,613▼ 0.9%
Financial charges65/66B-€1,785€4,527€4,221€4,776▲ 13.1%
Recurring financial charges65€320€1,785€4,527€4,221€4,776▲ 13.1%
Profit (loss) for the period before taxes9903-€21,542-€43,897-€37,698-€41,103-€17,642▲ 57.1%
Income taxes67/77€0-€3,395€0---
Profit (loss) for the period9904-€21,542-€40,502-€37,698-€41,103-€17,642▲ 57.1%
Profit (loss) for the period to be appropriated9905-€21,542-€40,502-€37,698-€41,103-€17,642▲ 57.1%
Line20202021202220232024Change
Assets
Total assets20/58€213,143€302,497€747,648€604,192€490,060▼ 18.9%
Formation expenses20€0-----
Fixed assets21/28€200,001€275,407€281,277€327,432€281,181▼ 14.1%
Intangible fixed assets21€163,348€246,157€259,137€235,301€206,018▼ 12.4%
Tangible fixed assets22/27€34,873€27,469€20,359€87,411€70,443▼ 19.4%
Plant, machinery and equipment23-€4,719€3,678€14,224€16,334▲ 14.8%
Furniture and vehicles24-€352€256€160€683▲ 327%
Leasing and similar rights25-€22,398€16,426€73,028€53,426▼ 26.8%
Financial fixed assets28€1,780€1,780€1,780€4,720€4,720=
Current assets29/58€13,142€27,090€466,371€276,759€208,879▼ 24.5%
Amounts receivable within one year40/41€11,501€3,649€268,158€274,533€123,349▼ 55.1%
Other amounts receivable41-€3,649€268,158€274,533€123,349▼ 55.1%
Cash at bank and in hand54/58€1,487€23,441€190,952€2,226€85,529▲ 3,742%
Deferred charges and accrued income490/1-€0€7,261€0--
Equity and liabilities
Total equity and liabilities10/49€213,143€302,497€747,648€604,192€490,060▼ 18.9%
Equity10/15€123,445€168,960€98,875€44,074-€26,175▼ 159%
Contributions10/11-€20,000€20,000€20,000€20,000=
Reserves13€1,485€1,485€1,485€1,485€1,485=
Non-distributable reserves130/1-€1,485€1,485€1,485€1,485=
Reserves not available under the articles1311-€1,485€1,485€1,485€1,485=
Profit (loss) carried forward14€902-€39,601-€77,299-€118,402-€136,043▼ 14.9%
Investment grants15-€187,076€154,689€140,991€88,384▼ 37.3%
Amounts payable17/49€89,699€133,537€648,774€560,118€516,235▼ 7.8%
Amounts payable after more than one year17€17,385€7,905€0€51,143€248,192▲ 385%
Financial debts170/4-€7,905€0€51,143€248,192▲ 385%
Amounts payable within one year42/48€72,314€125,632€136,876€202,703€214,952▲ 6.0%
Current portion of amounts payable after more than one year42-€9,384€7,683€12,156€12,951▲ 6.5%
Financial debts43-€25,000€25,000€25,000€0▼ 100%
Credit institutions430/8-€25,000€25,000€25,000€0▼ 100%
Trade debts44€27,162€57,247€58,461€110,065€159,662▲ 45.1%
Suppliers440/4-€57,247€58,461€110,065€159,662▲ 45.1%
Taxes, remuneration and social security45-€0-€9,749€11,224▲ 15.1%
Taxes450/3-€0----
Remuneration and social security454/9-€0-€9,749€11,224▲ 15.1%
Other amounts payable47/48-€34,001€45,733€45,732€31,114▼ 32.0%
Accrued charges and deferred income492/3--€511,897€306,272€53,091▼ 82.7%
Line20202021202220232024Change
Profit (loss) for the period9904-€21,542-€40,502-€37,698-€41,103-€17,642▲ 57.1%
+ Depreciation and write-downs630€9,242€28,203€38,410€47,155€58,322▲ 23.7%
Operating cash flow (approximation)-€12,299-€12,299€712€6,053€40,680▲ 572%
Investment in fixed assets (approximation)--€103,609-€44,280-€93,311-€12,071▲ 87.1%
Change in cash-€21,954€167,511-€188,726€83,303▲ 144%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
16-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
23-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet -€41,103
Net result drops to -€41,103, the lowest in the series; recovery starts the following year.
23-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Liquidity times 16current ratio 3.41
Current ratio from 0.22 to 3.41.
27-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €150,000Eq €168,960 ▲36.9%
Equity rises from €123,445 to €168,960.
28-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Equity above €100,000Eq €123,445 ▲287%
Equity rises from €31,928 to €123,445.
01-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts

We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2019
seat establishment The establishment unit on the map
Ground area
2,982 m²
Building footprint
930 m²
Volume, LiDAR
20 m³
Parcel 11809I2910/00R000, Flanders · tallest building 1.7 m. Linked by address, not a title deed.
34 companies at this address See who is registered here
1 establishment unit
Calidris Bio
Olieweg 95, 2020 AntwerpenAgents specialised in the wholesale of other particular products
since 20192.286.446.485
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11809I2910/00R000 Flanders 2,982 m² 1 · 930 m² 1.7 m
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Public money · subsidies and aid

Flemish government

2022 to 2025 · 3 entries · 478,185 EUR awarded · 5,372 EUR paid
Year Entries awardedpaid
2025 2 472,843 EUR30 EUR
2022 1 5,342 EUR5,342 EUR
Schemes
1 entry · 472,813 EUR · Fonds voor Innoveren en Ondernemen
1 entry · 5,342 EUR · 5,342 EUR paid · Departement Werk en Sociale Economie
1 entry · 30 EUR · 30 EUR paid · Fonds voor Innoveren en Ondernemen

European Union, budget

2022 to 2023 · 2 entries · 583,435 EUR in total
Year Entries awarded
2023 1 67,690 EUR
2022 1 515,745 EUR
Projects
LIKE-A-PRO - FROM NICHE TO MAINSTREAM - ALTERNATIVE PROTEINS FOR EVERYBODY AND EVERYWHERE
Horizon Europe · 01-11-2022 to 31-10-2026 · 515,745 EUR
BIOTECH4FOOD - ACCELERATION OF NEW PROMISING CIRCULAR AGRI-FOOD VALUE CHAINS AND SUSTAINABLE BIO-INDUSTRIAL INTERREGIONAL INVESTMENT IN SMES BY INTEGRATION OF ADVANCED BIOTECHNOLOGY
European Regional Development Fund · 01-11-2023 to 31-10-2026 · 67,690 EUR

European research

1 project · 515,750 EUR EU contribution
Programmes
1 entry · 515,750 EUR
Projects
From niche to mainstream - alternative proteins for everybody and everywhere
Horizon Europe · participant · 01-11-2022 to 31-10-2026 · 515,750 EUR · LIKE-A-PRO

Recognitions · licences · registrations

Food safety, FASFC

1 site
Antwerpen2.286.446.485
1 permission
Groothandelaar grondstoffen · since 01-08-2023

Similar companies · same sector, comparable size

Of 1,177 companies in sector 72109 we hold annual accounts for 717. 351 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded07-02-2019
Fiscal year end31-12
Activities, NACEBEL 2025
71121Engineering and related technical consultancy, excluding land surveyors
72109Other research and development on natural sciences
Contact
E-mail jgp@hotmail.beAntwerpen
Phone 0478280340Antwerpen
E-invoicing
Reachable via Peppol
Peppol ID 0208:0719970820
Also 9925:BE0719970820
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.